Abstract
A single dose of cefodizime (CDZM), ceftriaxone (CTRX), or spectinomycin (SPCM) is recommended for the treatment of gonococcal urethritis or uterine cervicitis in the era of multidrug-resistant Neisseria gonorrhoeae; namely, cefozopran-resistant N. gonorrhoeae (CZRNG). N. gonorrhoeae pharyngeal infection is not so rare in Japan; however, the proper treatment regimen for this infection is not clear. We previously found that a single dose of CDZM completely eradicated multidrug-resistant N. gonorrhoeae in patients with urethritis and uterine cervicitis, so we tried a single 1.0-g dose of CDZM for the treatment of N. gonorrhoeae pharyngeal infection, including infections with CZRNG. The eradication rate of N. gonorrhoeae from the pharynx was 63.0% with a single 1.0-g dose of CDZM, while the rate for CZRNG with the same dose of CDZM was 38.5%. N. gonorrhoeae was completely eradicated from the pharynx when patients received one or two additional doses of CDZM. Therefore, we concluded that two to three doses of CDZM were necessary for the treatment of N. gonorrhoeae pharyngeal infection including infection with CZRNG.
Similar content being viewed by others
References
T Iyoda T Saika A Kanayama M Hasegawa I Kobayashi Y Onoe et al. (2003) ArticleTitleBacteriological and epidemiological study on Nesseria gonorrhoeae isolated from the pharyngeal specimens of male and female patients with gonorrhoea (in Japanese) Kansenshogaku Zasshi 77 103–9 Occurrence Handle12661086
KA Workowski WC Levine (2002) ArticleTitleSexually transmitted diseases; treatment guidelines, 2002 MMWR 51 IssueIDRR06 1–80
M Ito M Yasuda S Yokoi S Ito Y Takahashi S Ishihara et al. (2004) ArticleTitleRemarkable increase in central Japan in 2001–2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones Antimicrob Agents Chemother 48 3185–7 Occurrence Handle15273147 Occurrence Handle1:CAS:528:DC%2BD2cXmtlKqur4%3D Occurrence Handle10.1128/AAC.48.8.3185-3187.2004
M Tanaka H Nakayama T Notomi S Irie Y Tsunoda A Okadome et al. (2004) ArticleTitleAntimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993–2002: continuous increasing of ciprofloxacin-resistant isolates Int J Antimicrob Agents 24 15–22 Occurrence Handle1:CAS:528:DC%2BD2cXnsFSgurc%3D Occurrence Handle10.1016/j.ijantimicag.2004.02.005
T Muratani S Akasaka T Kobayashi Y Yamada H Inatomi K Takahashi et al. (2001) ArticleTitleOutbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Nesseria gonorrhoeae in Japan Antimicrob Agents Chemother 45 3603–6 Occurrence Handle11709349 Occurrence Handle1:CAS:528:DC%2BD3MXovVOksLk%3D Occurrence Handle10.1128/AAC.45.12.3603-3606.2001
T Matsumoto T Muratani K Takahashi Y Ando Y Sato M Kurashima et al. (2006) ArticleTitleSingle dose of cefodizime completely eradicated multi-drug resistant strains of Neisseria gonorrhoeae in urethritis and uterine cervicitis J Infect Chemother 12 97–9 Occurrence Handle16648949 Occurrence Handle1:CAS:528:DC%2BD28XktVSgt7o%3D Occurrence Handle10.1007/s10156-006-0431-5
InstitutionalAuthorNameNational Committee for Clinical Laboratory Standards (1999) Performance standards for antimicrobial susceptibility testing, 9th informational supplement M7-A4 (M100-S9) National Committee for Clinical Laboratory Standards Wayne, PA
K Manavi H Young D Clutterbuch (2003) ArticleTitleSensitivity of microscopy for the rapid diagnosis of gonorrhoea in men and women and the role of gonorrhoea serovars Int J STD AIDS 14 390–4 Occurrence Handle12816666 Occurrence Handle10.1258/095646203765371277
K Manavi H Young A McMillan (2005) ArticleTitleThe outcome of oropharyngeal gonorrhoea treatment with different regimens Int J STD AIDS 16 68–70 Occurrence Handle15705277 Occurrence Handle1:STN:280:DC%2BD2M%2Fns1Kmuw%3D%3D Occurrence Handle10.1258/0956462052932566
MY Khan RP Gruninger SM Nelson SR Obald (1983) ArticleTitleComparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeae Antimicrob Agents Chemother 23 477–8 Occurrence Handle6303215 Occurrence Handle1:CAS:528:DyaL3sXhsVSnsbc%3D
RN Jones AL Barry C Thornbery HW Wilson (1981) ArticleTitleIn vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin Antimicrob Agents Chemother 20 760–8 Occurrence Handle6275785 Occurrence Handle1:CAS:528:DyaL38XmsFGhug%3D%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Matsumoto, T., Muratani, T., Takahashi, K. et al. Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection. J Infect Chemother 12, 145–147 (2006). https://doi.org/10.1007/s10156-006-0444-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10156-006-0444-0